Mikael Boberg
- Pharmacology top 5%
- Molecular Biology
- Pediatrics, Perinatology and Child Health top 10%
- Oncology
- Pharmacology
- Co-authors
- Allan E. RettieAlbert W. RettenmeierThomas A. BaillieJ. Steven LeederBhagwat PrasadAndrea GaedigkRobin E. PearceDeepak Bhatt
- Topics
- Pharmacogenetics and Drug Metabolism (5 papers)Trypanosoma species research and implications (3 papers)Research on Leishmaniasis Studies (2 papers)
- Partner nations
- SwedenUnited StatesFinland
In The Last Decade
Mikael Boberg
11 papers receiving 365 citations
Peers
Comparison fields: 5 of 80
- Pharmacology 132
- Molecular Biology 95
- Pediatrics, Perinatology and Child Health 95
- Oncology 67
- Pharmacology 54
Countries citing papers authored by Mikael Boberg
This map shows the geographic impact of Mikael Boberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikael Boberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikael Boberg more than expected).
Fields of papers citing papers by Mikael Boberg
This network shows the impact of papers produced by Mikael Boberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikael Boberg. The network helps show where Mikael Boberg may publish in the future.
Co-authorship network of co-authors of Mikael Boberg
This figure shows the co-authorship network connecting the top 25 collaborators of Mikael Boberg. A scholar is included among the top collaborators of Mikael Boberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikael Boberg. Mikael Boberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 5 | |
| 5 | 7 | |
| 6 | 1 | |
| 7 | 90 | |
| 8 | 1 | |
| 9 | 86 | |
| 10 | 66 | |
| 11 | 110 | |
| 12 | 2 |
About Mikael Boberg
Mikael Boberg is a scholar working on Pharmacology, Pharmaceutical Science and Clinical Biochemistry, having authored 12 papers that have together received 371 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (5 papers), Trypanosoma species research and implications (3 papers) and Research on Leishmaniasis Studies (2 papers). The work is most often cited by research in Pharmacology (132 citations), Pediatrics, Perinatology and Child Health (95 citations) and Clinical Biochemistry (27 citations). Mikael Boberg has collaborated with scholars based in Sweden, United States and Finland. Frequent co-authors include Allan E. Rettie, Albert W. Rettenmeier, Thomas A. Baillie, J. Steven Leeder, Bhagwat Prasad, Andrea Gaedigk, Robin E. Pearce, Deepak Bhatt, Aanchal Mehrotra and Lena Kilander. Their work appears in journals such as Journal of Biological Chemistry, The FASEB Journal and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.